US 7264820
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline
granted A61KA61K2039/5152A61K2039/55522
Quick answer
US patent 7264820 (Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline) held by The Regents of the University of California expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/5152, A61K2039/55522, A61K2039/55527, A61K2039/55533